ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2020
May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.
Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- COVID-19 and first manic episodes: a systematic review.Psychiatry research · 2022Pooled it
- Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.Journal of neurology · 2021Pooled it
- A rare clinical presentation after COVID-19: Manic episode with psychotic features.Psychiatry research case reports · 2023Article
- Guillan-barre syndrome during COVID-19 pandemic: a case series from Syria.Annals of medicine and surgery (2012) · 2023Article
- Cognitive inhibition deficit in long COVID-19: An exploratory study.Frontiers in neurology · 2023Article
- Acute and long‑term psychiatric symptoms associated with COVID‑19 (Review).Biomedical reports · 2023Review
- Reactive gliosis and neuroinflammation: prime suspects in the pathophysiology of post-acute neuroCOVID-19 syndrome.Frontiers in neurology · 2023Review
- Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment.CNS drugs · 2022Review
- Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021Review
- Psychotic Agitation in a Patient with COVID-19: Pathogenesis or Iatrogenesis?Psychiatry and clinical psychopharmacology · 2021Article
- SARS-CoV-2-associated first episode of acute mania with psychotic features.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021Article
- A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19.Journal of psychosomatic research · 2021Review
- Laboratory biomarkers associated with COVID-19 severity and management.Clinical immunology (Orlando, Fla.) · 2020Article
- Reissuing the sigma receptors for SARS-CoV-2.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020Article
Corrections and comments
- Comment on
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.